These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22211863)

  • 1. Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
    Broussalis E; Hutterer M; Oppermann K; Wipfler P; Pilz G; Harrer A; Haschke-Becher E; Golaszewski S; Schönauer U; Weis S; Killer-Oberpfalzer M; Mc Coy M; Trinka E; Kraus J
    Acta Neurol Scand; 2012 Sep; 126(3):e11-6. PubMed ID: 22211863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology.
    Schroers R; Baraniskin A; Heute C; Vorgerd M; Brunn A; Kuhnhenn J; Kowoll A; Alekseyev A; Schmiegel W; Schlegel U; Deckert M; Pels H
    Eur J Haematol; 2010 Dec; 85(6):520-8. PubMed ID: 20727005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages of flow cytometry immunophenotyping for the diagnosis of central nervous system non-Hodgkin's lymphoma in AIDS patients.
    Subirá D; Górgolas M; Castañón S; Serrano C; Román A; Rivas F; Tomás JF
    HIV Med; 2005 Jan; 6(1):21-6. PubMed ID: 15670248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
    Sancho JM; Orfao A; Quijano S; García O; Panizo C; Pérez-Ceballos E; Deben G; Salar A; González-Barca E; Alonso N; García-Vela JA; Capote J; Peñalver FJ; Provencio M; Arias J; Plaza J; Caballero D; Morado M; Feliu E; Ribera JM;
    Eur J Haematol; 2010 Oct; 85(4):321-8. PubMed ID: 20528905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of multidimensional flow cytometry in detecting occult leptomeningeal disease in newly diagnosed aggressive B-cell lymphomas.
    Di Noto R; Scalia G; Abate G; Gorrese M; Pascariello C; Raia M; Morabito P; Capone F; Pardo CL; Mirabelli P; Mariotti E; Del Vecchio L
    Leuk Res; 2008 Aug; 32(8):1196-9. PubMed ID: 18262645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia].
    Jiang NG; Zhu HL; Zeng TT; Su J; Zhang Y; Jia YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):664-8. PubMed ID: 20848792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells.
    Babusíková O; Zelezníková T
    Neoplasma; 2004; 51(5):345-51. PubMed ID: 15640938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
    Chamberlain MC; Glantz M; Groves MD; Wilson WH
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.
    Quijano S; López A; Manuel Sancho J; Panizo C; Debén G; Castilla C; Antonio García-Vela J; Salar A; Alonso-Vence N; González-Barca E; Peñalver FJ; Plaza-Villa J; Morado M; García-Marco J; Arias J; Briones J; Ferrer S; Capote J; Nicolás C; Orfao A;
    J Clin Oncol; 2009 Mar; 27(9):1462-9. PubMed ID: 19224854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary natural killer/T-cell lymphoma presenting as leptomeningeal disease.
    Liao B; Kamiya-Matsuoka C; Gong Y; Chen M; Wolf BA; Fowler NH
    J Neurol Sci; 2014 Aug; 343(1-2):46-50. PubMed ID: 24880537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptomeningeal lymphoma in a child with acquired immune deficiency syndrome.
    Scrigni A; Nastri M; Rodríguez de Schiavi S; Czornyj L; Felice M; Mantese B
    Neuropediatrics; 2006 Jun; 37(3):121-5. PubMed ID: 16967361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal involvement by relapsed follicular lymphoma detected by flow cytometry despite exceedingly low white blood cell counts in cerebrospinal fluid: A case report.
    Hafeez S; Cho WC; Shen P
    Indian J Pathol Microbiol; 2020; 63(1):131-133. PubMed ID: 32031143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.
    Gleissner B; Siehl J; Korfel A; Reinhardt R; Thiel E
    Neurology; 2002 Feb; 58(3):390-6. PubMed ID: 11839837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
    Aviles A; Gómez R; Salas J
    Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary leptomeningeal T-cell lymphoma: a case and a review of primary T-cell lymphoma of the central nervous system.
    Grove A; Vyberg M
    Clin Neuropathol; 1993; 12(1):7-12. PubMed ID: 8440081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.
    Taylor JW; Flanagan EP; O'Neill BP; Siegal T; Omuro A; Deangelis L; Baehring J; Nishikawa R; Pinto F; Chamberlain M; Hoang-Xuan K; Gonzalez-Aguilar A; Batchelor T; Blay JY; Korfel A; Betensky RA; Lopes MB; Schiff D
    Neurology; 2013 Nov; 81(19):1690-6. PubMed ID: 24107866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten antibodies, six colors, twelve parameters: a multiparameter flow cytometric approach to evaluate leptomeningeal disease in B-cell non-Hodgkin's lymphomas.
    Stacchini A; Aliberti S; Demurtas A; Benevolo G; Godio L
    Cytometry B Clin Cytom; 2012 May; 82(3):139-44. PubMed ID: 22328059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebrospinal fluid cytology in meningeal invasion of leukemia and malignant lymphoma. Reliable diagnosis by immunocytochemistry].
    Bamborschke S; Huber M
    Nervenarzt; 1992 Apr; 63(4):218-22. PubMed ID: 1594087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.
    Bromberg JE; Breems DA; Kraan J; Bikker G; van der Holt B; Smitt PS; van den Bent MJ; van't Veer M; Gratama JW
    Neurology; 2007 May; 68(20):1674-9. PubMed ID: 17502548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.